Symposium:
023. Impact of Sepsis Measures
Thursday, October 5, 2017: 8:30 AM-10:00 AM
Room: 11AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the current epidemiologic and incidence data on sepsis
  • list important aspects of the CMS sepsis measure
  • describe desirable features of new sepsis measures

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Nurses, Pharmacists

Tracks: Epidemiology and Infection Control, Adult ID


Chairs:  Arjun Srinivasan, MD, FSHEA, Centers for Disease Control and Prevention and Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA, Perelman School of Medicine, University of Pennsylvania

Moderators:  David Warren, MD, MPH, Washington University in St Louis and Anthony E. Fiore, MD, Centers for Disease Control and Prevention

Presentations:
8:30 AM
61
8:55 AM
62
Development of the CMS Sepsis Measure
Bob Dickerson, RRT, MSHSA

9:20 AM
63
Next Steps in Sepsis Surveillance
Lauren Epstein, MD, MSc

9:45 AM
Q&A

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-235-L01-P

Disclosures:

A. Srinivasan, None

E. Lautenbach, Merck: Scientific Advisor , Consulting fee
Nabriva: Scientific Advisor , Consulting fee

A. E. Fiore, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.